Sight Sciences

Rank#8253

Market Cap299.25M

CountryUnited States

Summary

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.

History

Sight Sciences was founded in San Mateo, California in 2008 with a mission to develop solutions that improve the health of eyes and empower the people who dedicate their lives to caring for them. Since then, we have built a strong capability in medical device design and manufacturing, combining the company’s unique engineering design and deep ophthalmic expertise. Our Team brings decades of cumulative experience in medical device R&D and a breadth of experience in various ophthalmic subspecialties and related industries.

Mission

Our mission is to develop technologies that enhance eye health and empower the people who dedicate their lives to caring for eyes.

Vision

Our vision is to become a global leader in eye health solutions and set the standard for treating a broad spectrum of eye disorders.

References

https://in.investing.com/equities/sight-sciences

https://www.comparably.com/companies/vision/mission

https://www.crunchbase.com/organization/sight-sciences

https://finance.yahoo.com/quote/SGHT/

https://www.sightsciences.com

https://sec.report/CIK/0001531177

Leadership team